Skip to main content
Fig. 6 | BMC Genomics

Fig. 6

From: Upregulation of CALD1 predicted a poor prognosis for platinum-treated ovarian cancer and revealed it as a potential therapeutic resistance target

Fig. 6

The Immunohistochemistry (IHC) of CALD1 in different kinds of OC and corresponding normal tissues based on the Human Protein Atlas (HPA). A Normal ovarian tissue (Staining: High; Intensity: Strong; Quantity: > 75%). B Ovarian serous cystadenocarcinoma (Staining: High; Intensity: Strong; Quantity: > 75%). C Ovarian mucinous cystadenocarcinoma (Staining: High; Intensity: Strong; Quantity: > 75%). D Endometroid carcinoma of ovary (Staining: Medium; Intensity: Moderate; Quantity: 75%-25%)

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us